RaySearch Laboratories
Logotype for RaySearch Laboratories

RaySearch Laboratories (RAY) investor relations material

RaySearch Laboratories Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for RaySearch Laboratories
Q4 2025 earnings summary12 Feb, 2026

Executive summary

  • Achieved record net sales in Q4 2025, up 16% year-over-year to SEK 375 million, and full-year net sales up 13% to SEK 1,344 million, both all-time highs, with strong organic growth despite currency and geopolitical challenges.

  • Recurring support revenue accounted for 39% of total revenues for the year, reflecting increased business robustness.

  • Strong license sales and high customer activity, with major orders and installations at leading cancer centers in the US, UK, Germany, and Poland.

  • Major clinical milestones included the world's first clinical proton arc treatments and first online adaptive treatment on a standard linac.

  • Updated dividend policy to distribute 50% of annual profit after tax, with a proposed dividend of SEK 4.00 per share for 2025.

Financial highlights

  • Q4 operating profit rose 25% to SEK 92 million, with a 24% EBIT margin; adjusted for currency losses, margin would have been 27%.

  • Full-year operating profit reached SEK 292 million (22% margin); adjusted EBIT was SEK 353 million (26% margin).

  • Order intake increased 8% in Q4 and 17% for the full year, despite currency headwinds.

  • Cash flow in Q4 improved to SEK 91 million, with year-end cash balance at SEK 407 million and no loans.

  • Free cash flow for the full year was SEK 82 million, impacted by higher working capital.

Outlook and guidance

  • Confident in achieving at least a 25% EBIT margin in 2026, with continued focus on sales growth and improved cash flow.

  • Board proposes a dividend of SEK 4 per share for 2025, up from SEK 3, and revises policy to distribute 50% of profit after tax annually from 2026.

  • New medium-term financial targets, including margin and possibly sales, to be communicated during 2026.

Impact of online adaptive treatment on market reach
How does the new dividend policy affect capital allocation?
What is the unhedged FX impact on order backlog?
Order backlog decrease impact on future growth?
Pinnacle conversion outlook for 2026
Timeline for new therapy area approvals
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next RaySearch Laboratories earnings date

Logotype for RaySearch Laboratories
Q1 202629 Apr, 2026
RaySearch Laboratories
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next RaySearch Laboratories earnings date

Logotype for RaySearch Laboratories
Q1 202629 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

RaySearch Laboratories AB, a global medical technology company, develops software solutions for cancer treatment. RxSight ™ is the first systems biology platform for personalized medicine to generate cancer patient-specific clinical trial plans from tissue slides, enabling better targeting of personalized therapy protocols using patient tissue. Its software solutions help doctors find the right combination of cells and drugs to fit their patients' specific needs, track tumor growth in real-time, increase efficiency in clinical trials, and help match the right patients with the right treatments. RaySearch Laboratories has successfully completed several rounds of funding and secured many high-profile partnerships in its short history.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage